TUESDAY, Oct. 24, 2017 (HealthDay News) — The high cost of cancer care inside United States has led more than one-quarter of patients to cut back on some part of their treatment, a brand new survey reveals.
Commissioned by the American Society of Clinical Oncology (ASCO), the report found in which 27 percent of cancer survivors or close relatives of a cancer patient said they’d skipped doctor visits or taken some other steps to reduce health costs.
To save money, nearly one in 10 said they had avoided doctor appointments. Eight percent had refused treatment; postponed filling or not filled prescriptions; or skipped doses of prescribed medications. along with 7 percent said they had cut pills in half, according to the survey of more than 4,000 adults.
Such measures can jeopardize treatment success, ASCO says.
“We should all be alarmed in which Americans are potentially risking not only their health, although also their lives, due to high treatment costs,” ASCO Chief Medical Officer Dr. Richard Schilsky said in a news Discharge via the group.
“No patient or family member should have to face an impossible choice — between their cancer treatment along with food, shelter, clothing along with some other necessary expenses,” Schilsky said.
“Adjusting the prescribed dose of a cancer medication either by skipping doses or cutting pills is actually dangerous, along with many health care providers may be unaware in which their patients are putting themselves at risk This kind of way,” he noted.
Most survey respondents said the federal government should take action to lower prescription drug costs.
For example, 92 percent said Medicare should be allowed to directly negotiate prescription drug prices with drug makers, while 86 percent said the government should regulate the cost of cancer drugs to lower their costs. along with eight in 10 said the item should be legal for U.S. residents to buy cancer drugs via some other countries.
More than 0 percent also said the government should provide significant funding to diagnose, prevent along with treat cancer. along with nearly three-quarters said the government should spend more to develop cancer treatments along with cures, even if the item means higher taxes or adding to the deficit.
“Federal investment in cancer research plays a critical role inside search for brand new cures, along with Americans clearly recognize This kind of. This kind of poll shows in which people are not only expecting, although counting on Congress along with the administration to invest more in research in which will deliver the next generation of cures to patients,” said ASCO President Dr. Bruce Johnson.
“More funding for cancer research would likely mean more innovation, more studies launched, more patients enrolled in clinical trials, more researchers entering the field, along with faster progress toward brand new along with much better treatments for patients,” he said.
While supporting cancer research, Americans seem less willing to fund cancer prevention. Less than half the respondents said more should be spent on cancer prevention. along with just 54 percent said the government should spend more to help Americans afford cancer screenings along with care.
The survey also found many Americans unaware of certain cancer risks.
For example, less than one-third know in which obesity along with alcohol are risk factors for cancer.
The study, released Oct. 24, was conducted online by The Harris Poll via July 10-18, 2017.
— Robert Preidt
Copyright © 2017 HealthDay. All rights reserved.
SOURCE: American Society of Clinical Oncology, news Discharge, Oct. 24, 2017
Subscribe to MedicineNet’s Cancer Report Newsletter